Drugs / Vesomni®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06546735 Comparator | Nov 2026 → Apr 2028 expected | benign prostatic hyperplasia | Eurofarma Laboratorios S.A. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vesomni | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06546735 ↗ |